ScholarLens Back to search
2020•Journal of CardiologyOpen access

Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure

Koji Takagi, Naoki Sato, Shiro Ishihara, Hayano Iha, Noriyuki Kobayashi, Yusuke Ito, Tsuyoshi Nohara, Satoru Ohkuma, Tatsuya Mitsuishi, Atsushi Ishizuka, Shota Shigihara, Michiko Sone, Kenji Nakama, Hideo Tokuyama, Toshiya Omote, Arifumi Kikuchi, Shunichi Nakamura, Eisei Yamamoto, Masahiro Ishikawa, Kenichi Amitani, Naoto Takahashi, Yūji Maruyama, Hajime Imura, Wataru Shimizu

Open full text 5 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Furosemide, Tolvaptan, Medicine, Intravascular volume status, Heart failure, Diuretic, Internal medicine, Cardiology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure — Research Paper | ScholarLens